Dyskinesia Medication-induced

• CLINICAL_TRIALS trial_result · 2021-05-26
  Clinical Trial Update: AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia [Phase 2]

  Phase 2 clinical trial evaluating AV-101 (L-4-chlorokynurenine) in Parkinson's disease patients with levodopa-induced dyskinesia; status cur…

• CLINICAL_TRIALS trial_result · 2018-10-11
  Clinical Trial Update: Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) [Phase 2]

  Phase 2 clinical trial investigating transcranial static magnetic field stimulation to prevent levodopa-induced dyskinesias in Parkinson's d…